Ricky Hopson, President, Clinical Development & Supply at Catalent, Inc. (CTLT), sold 1,494 shares at $107.67 ($161K) on 2022-07-27, disclosed to the SEC on 2022-07-28.
Open-market sale of $161k CTLT by President, Clinical Development & Supply. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.90 | 312 | $33K | 20.8% |
| 2 | $107.67 | 591 | $64K | 39.6% |
| 3 | $107.67 | 591 | $64K | 39.6% |
| Total | $107.51 avg | 1,494 | $161K | 100% |
| Filing → |
| CTLT | SELL | 2024-06-05 | $152K | — | Filing → |
| CTLT | SELL | 2023-08-25 | $12K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $9K | — | Filing → |